Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.

Also called NCT03303612

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03303612
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada, France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03303612. Randomized; no masking; primary purpose treatment. Start 2017-10-15 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
Acronym
COME-TAVI
Condition
Left Bundle-Branch Block
Condition
Aortic Valve Stenosis
Intervention (Device)
Pacemaker implant
Intervention (Device)
Transcutaneous cardiac monitor
Lead sponsor
Montreal Heart Institute (class: other)

Record details

Record id
cardio:ct-nct03303612
Content hash
1d60c5127350e3ee70b27ae4a5abad578feb7cbce04dded73fb0b3119b0f4fd6